JANX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 29.40%

Insider Buying (Last 12 Months): $67,589,565.00

Insider Selling (Last 12 Months): $188,518,368.67

Janux Therapeutics Insider Trading History Chart

Janux Therapeutics Share Price & Price History

^$29.69

▲ +1 (3.49%)

As of 04/17/2025 05:00 PM ET

Days: 30 | 90 | 365

Janux Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/7/2025	Ra Capital Management, L.P.	Director	Buy	110,206	$31.02	$3,418,590.12	10,141,287
3/5/2025	Ra Capital Management, L.P.	Director	Buy	341,742	$30.64	$10,470,974.88	9,658,988
3/3/2025	Andrew Hollman Meyer	Insider	Sell	3,334	$32.15	$107,188.10	82,139
2/3/2025	Andrew Hollman Meyer	Insider	Sell	3,334	$42.29	$140,994.86	82,139
1/7/2025	David Alan Campbell	CEO	Sell	5,000	$60.00	$300,000.00	293,054
1/2/2025	Andrew Hollman Meyer	Insider	Sell	13,334	$54.88	$731,769.92	82,139
12/24/2024	David Alan Campbell	CEO	Sell	25,000	$56.19	$1,404,750.00	217,054
12/3/2024	David Alan Campbell	CEO	Sell	15,000	$67.00	$1,005,000.00	242,054
11/25/2024	David Alan Campbell	CEO	Sell	25,000	$51.60	$1,290,000.00	257,054
10/28/2024	David Alan Campbell	CEO	Sell	25,000	$53.54	$1,338,500.00	282,054
10/18/2024	Ra Capital Management, L.P.	Director	Buy	1,200,000	$44.75	$53,700,000.00	9,317,246
10/17/2024	Ventures Xi L.P. Avalon	Major Shareholder	Sell	1,843	$50.02	$92,186.86	6,371
9/30/2024	Ventures Xi L.P. Avalon	Major Shareholder	Sell	958	$46.24	$44,297.92	6,887
9/27/2024	Andrew Hollman Meyer	Insider	Sell	50,000	$45.96	$2,298,000.00	67,592
9/27/2024	David Alan Campbell	CEO	Sell	25,000	$46.31	$1,157,750.00	307,054
9/27/2024	Ventures Xi L.P. Avalon	Major Shareholder	Sell	49,231	$46.45	$2,286,779.95	6,926
9/12/2024	Ventures Xi L.P. Avalon	Major Shareholder	Sell	158,031	$47.00	$7,427,457.00	2,959,175
9/9/2024	Ventures Xi L.P. Avalon	Major Shareholder	Sell	2,182	$42.33	$92,364.06	7,000
9/6/2024	Ventures Xi L.P. Avalon	Major Shareholder	Sell	108,365	$42.00	$4,551,330.00	3,162,851
6/3/2024	Jay Lichter	Director	Sell	1,500,000	$54.75	$82,125,000.00	633,673
6/3/2024	Tighe Reardon	CFO	Sell	822,721	$54.75	$45,043,974.75	633,673
6/3/2024	Ventures Xi L.P. Avalon	Major Shareholder	Sell	677,279	$54.75	$37,081,025.25	3,271,216
11/13/2023	Ventures Xi L.P. Avalon	Major Shareholder	Buy	849,854	$5.87	$4,988,642.98	849,854
7/19/2023	Ra Capital Management, L.P.	Director	Buy	495,008	$12.46	$6,167,799.68	8,117,246

See Full Table

SEC Filings (Institutional Ownership Changes) for Janux Therapeutics (NASDAQ:JANX)

75.39% of Janux Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Janux Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/17/2025	FNY Investment Advisers LLC	2,460	$66K	0.0%	+6,928.6%	0.004%
4/17/2025	Exchange Traded Concepts LLC	4,043	$0.11M	0.0%	+20.4%	0.007%
4/15/2025	SG Americas Securities LLC	28,631	$0.77M	0.0%	N/A	0.048%
4/15/2025	Avanza Fonder AB	3,049	$86K	0.0%	+17.0%	0.005%
4/8/2025	Rhumbline Advisers	42,650	$1.15M	0.0%	+11.8%	0.072%
4/7/2025	GAMMA Investing LLC	1,674	$45K	0.0%	+1,574.0%	0.003%
3/24/2025	Wellington Management Group LLP	535,396	$28.67M	0.0%	+3,592.9%	0.906%
3/18/2025	California State Teachers Retirement System	36,735	$1.97M	0.0%	+82.2%	0.062%
2/28/2025	Universal Beteiligungs und Servicegesellschaft mbH	46,264	$2.48M	0.0%	N/A	0.088%
2/19/2025	GF Fund Management CO. LTD.	1,102	$59K	0.0%	N/A	0.002%
2/18/2025	Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.	429,392	$22.99M	2.8%	-9.0%	0.818%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	165,737	$8.87M	0.0%	+532.7%	0.316%
2/17/2025	Woodline Partners LP	1,852,187	$99.17M	0.7%	+15.7%	3.529%
2/17/2025	Squarepoint Ops LLC	41,176	$2.21M	0.0%	+155.1%	0.078%
2/17/2025	Two Sigma Investments LP	59,974	$3.21M	0.0%	-22.3%	0.114%
2/17/2025	Troluce Capital Advisors LLC	32,297	$1.73M	0.1%	N/A	0.062%
2/17/2025	Tang Capital Management LLC	50,000	$2.68M	0.2%	N/A	0.095%
2/17/2025	Tema Etfs LLC	5,223	$0.28M	0.1%	N/A	0.010%
2/17/2025	Stempoint Capital LP	145,876	$7.81M	1.9%	+195.2%	0.278%
2/17/2025	Shay Capital LLC	7,000	$0.38M	0.1%	N/A	0.013%
2/17/2025	Sphera Funds Management LTD.	68,333	$3.66M	0.7%	N/A	0.130%
2/17/2025	Rafferty Asset Management LLC	52,168	$2.79M	0.0%	-20.6%	0.099%
2/17/2025	Ratan Capital Management LP	179,307	$9.60M	1.5%	+522.6%	0.342%
2/17/2025	Point72 Asset Management L.P.	621,383	$33.27M	0.1%	+57.0%	1.184%
2/17/2025	ProShare Advisors LLC	10,384	$0.56M	0.0%	+23.9%	0.020%
2/17/2025	Prosight Management LP	329,768	$17.66M	4.9%	+60.9%	0.628%
2/17/2025	MPM Bioimpact LLC	230,000	$12.31M	1.7%	+34.4%	0.438%
2/17/2025	Paradigm Biocapital Advisors LP	3,515,986	$188.25M	6.5%	+46.5%	6.699%
2/17/2025	Nuveen Asset Management LLC	127,747	$6.84M	0.0%	-23.5%	0.243%
2/17/2025	Nicholas Investment Partners LP	50,958	$2.73M	0.2%	N/A	0.097%
2/17/2025	Orbimed Advisors LLC	758,566	$40.61M	0.9%	-39.7%	1.445%
2/17/2025	Millennium Management LLC	116,102	$6.22M	0.0%	N/A	0.221%
2/17/2025	Lazard Asset Management LLC	82,005	$4.39M	0.0%	N/A	0.156%
2/17/2025	Integral Health Asset Management LLC	200,000	$10.71M	0.9%	N/A	0.381%
2/17/2025	Janus Henderson Group PLC	3,562,402	$190.62M	0.1%	+41.2%	6.788%
2/17/2025	Ensign Peak Advisors Inc	142,300	$7.62M	0.0%	+7.0%	0.271%
2/17/2025	Farallon Capital Management LLC	48,000	$2.57M	0.0%	N/A	0.091%
2/17/2025	Fred Alger Management LLC	23,501	$1.26M	0.0%	N/A	0.045%
2/17/2025	Deutsche Bank AG	93,029	$4.98M	0.0%	+386.6%	0.177%
2/17/2025	Driehaus Capital Management LLC	515,646	$27.61M	0.2%	N/A	0.983%
2/17/2025	Crestline Management LP	23,414	$1.25M	0.0%	N/A	0.045%
2/17/2025	Cubist Systematic Strategies LLC	40,349	$2.16M	0.0%	N/A	0.077%
2/17/2025	Cutter Capital Management LP	120,000	$6.43M	2.6%	N/A	0.229%
2/17/2025	Brevan Howard Capital Management LP	4,137	$0.22M	0.0%	N/A	0.008%
2/17/2025	Avidity Partners Management LP	741,900	$39.72M	3.9%	+32.0%	1.414%
2/17/2025	Bamco Inc. NY	6,000	$0.32M	0.0%	N/A	0.011%
2/17/2025	Bayesian Capital Management LP	8,300	$0.44M	0.1%	N/A	0.016%
2/17/2025	Bank of America Corp DE	794,761	$42.55M	0.0%	+1,165.6%	1.514%
2/17/2025	BNP Paribas Financial Markets	6,828	$0.37M	0.0%	N/A	0.013%
2/17/2025	Ameriprise Financial Inc.	14,906	$0.80M	0.0%	+182.8%	0.028%
2/17/2025	Algert Global LLC	64,961	$3.48M	0.1%	+165.5%	0.124%
2/17/2025	Alyeska Investment Group L.P.	344,916	$18.47M	0.1%	+69.8%	0.657%
2/17/2025	Ally Bridge Group NY LLC	90,292	$4.83M	4.1%	-17.0%	0.172%
2/14/2025	RA Capital Management L.P.	10,365,652	$554.98M	7.3%	+13.1%	19.752%
2/14/2025	Freestone Grove Partners LP	6,807	$0.36M	0.0%	N/A	0.013%
2/14/2025	Samsara BioCapital LLC	11,263	$0.60M	0.1%	-50.0%	0.021%
2/14/2025	Schonfeld Strategic Advisors LLC	109,500	$5.86M	0.0%	-26.7%	0.209%
2/14/2025	First Light Asset Management LLC	313,782	$16.80M	1.6%	N/A	0.598%
2/14/2025	Northern Trust Corp	308,800	$16.53M	0.0%	+15.9%	0.588%
2/14/2025	The Manufacturers Life Insurance Company	63,512	$3.40M	0.0%	+107.6%	0.121%
2/14/2025	Artia Global Partners LP	162,976	$8.73M	3.1%	N/A	0.311%
2/14/2025	Tri Locum Partners LP	236,407	$12.66M	2.6%	N/A	0.450%
2/14/2025	Aquatic Capital Management LLC	6,156	$0.33M	0.0%	N/A	0.012%
2/14/2025	Boothbay Fund Management LLC	26,897	$1.44M	0.0%	-125.3%	0.051%
2/14/2025	Virtus ETF Advisers LLC	1,156	$62K	0.0%	-46.9%	0.002%
2/14/2025	Gilder Gagnon Howe & Co. LLC	52,379	$2.80M	0.0%	+361.5%	0.100%
2/14/2025	Lord Abbett & CO. LLC	1,267,803	$67.88M	0.2%	+80.2%	2.416%
2/14/2025	Voya Investment Management LLC	44,254	$2.37M	0.0%	-36.6%	0.084%
2/14/2025	Adage Capital Partners GP L.L.C.	3,061,750	$163.93M	0.3%	+47.6%	5.834%
2/14/2025	Price T Rowe Associates Inc. MD	1,109,978	$59.43M	0.0%	+596.3%	2.115%
2/14/2025	Rock Springs Capital Management LP	204,466	$10.95M	0.4%	N/A	0.390%
2/14/2025	Tower Research Capital LLC TRC	3,827	$0.21M	0.0%	+878.8%	0.007%
2/14/2025	Teachers Retirement System of The State of Kentucky	12,200	$0.65M	0.0%	N/A	0.023%
2/14/2025	MetLife Investment Management LLC	17,298	$0.93M	0.0%	+5.8%	0.033%
2/14/2025	Dimensional Fund Advisors LP	20,048	$1.07M	0.0%	-1.6%	0.038%
2/14/2025	First Trust Advisors LP	128,062	$6.86M	0.0%	N/A	0.244%
2/13/2025	Marshall Wace LLP	22,348	$1.20M	0.0%	-53.5%	0.043%
2/13/2025	Zacks Investment Management	38,173	$2.04M	0.0%	-9.4%	0.073%
2/13/2025	EAM Investors LLC	53,026	$2.84M	0.4%	N/A	0.101%
2/13/2025	Barclays PLC	263,970	$14.13M	0.0%	+51.7%	0.503%
2/13/2025	Quinn Opportunity Partners LLC	20,000	$1.07M	0.1%	N/A	0.038%
2/13/2025	Kennedy Capital Management LLC	12,713	$0.68M	0.0%	+7.9%	0.024%
2/13/2025	Legal & General Group Plc	34,540	$1.85M	0.0%	+45.3%	0.066%
2/13/2025	Invesco Ltd.	284,662	$15.24M	0.0%	+2,764.4%	0.542%
2/13/2025	ADAR1 Capital Management LLC	31,509	$1.69M	0.3%	+142.4%	0.060%
2/13/2025	Cerity Partners LLC	4,478	$0.24M	0.0%	N/A	0.009%
2/13/2025	FMR LLC	8,669,941	$464.19M	0.0%	+10.8%	16.520%
2/13/2025	Springhill Fund Asset Management HK Co Ltd	29,600	$1.59M	2.6%	N/A	0.056%
2/13/2025	Russell Investments Group Ltd.	1,011	$54K	0.0%	+77.7%	0.002%
2/13/2025	Rhenman & Partners Asset Management AB	170,000	$9.10M	0.9%	+59.1%	0.324%
2/13/2025	Wells Fargo & Company MN	13,251	$0.71M	0.0%	+52.9%	0.025%
2/13/2025	Pamalican Asset Management Ltd	25,000	$1.34M	0.6%	N/A	0.048%
2/12/2025	Trexquant Investment LP	65,858	$3.53M	0.0%	N/A	0.125%
2/12/2025	Geode Capital Management LLC	714,956	$38.29M	0.0%	+7.9%	1.362%
2/12/2025	Franklin Resources Inc.	497,287	$26.63M	0.0%	+2,519.6%	0.948%
2/12/2025	Meeder Asset Management Inc.	2,972	$0.16M	0.0%	N/A	0.006%
2/12/2025	Wellington Management Group LLP	535,396	$28.67M	0.0%	+3,592.9%	1.020%
2/12/2025	Schroder Investment Management Group	156,874	$8.24M	0.0%	+111.2%	0.299%
2/12/2025	DnB Asset Management AS	5,778	$0.31M	0.0%	-7.6%	0.011%
2/12/2025	Orion Portfolio Solutions LLC	4,913	$0.26M	0.0%	-25.6%	0.009%

Data available starting January 2016

See Full Table

Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr) platforms technology to treat patients suffering from cancer. The company's clinical candidates comprise JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical trial in adults for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and the vasculature of other tumors; and JANX008, an epidermal growth factor receptor or EGFR-TRACTr that is in Phase 1 clinical trial for the treatment of multiple solid cancers, including colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer, and renal cell carcinoma. Its development pipeline also consists of discovery stage products. The company has strategic research collaboration agreement with Merck Sharp & Dohme Corp. to develop TRACTr product candidates. Janux Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.

Today's Range

Now: $29.69

$28.60

$29.82

50 Day Range

MA: $30.67

$23.79

$37.33

52 Week Range

Now: $29.69

$22.52

$71.71

Volume

367,166 shs

Average Volume

854,113 shs

Market Capitalization

$1.75 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.27

Who are the company insiders with the largest holdings of Janux Therapeutics?: Janux Therapeutics' top insider investors include:
Ra Capital Management, LP (Director)
Ventures Xi LP Avalon (Major Shareholder)
Jay Lichter (Director)
Tighe Reardon (CFO)
David Alan Campbell (CEO)
Andrew Hollman Meyer (Insider)
Learn More about top insider investors at Janux Therapeutics.
Who are the major institutional investors of Janux Therapeutics?: Janux Therapeutics' top institutional shareholders include:
Rhumbline Advisers — 0.07%
SG Americas Securities LLC — 0.05%
Exchange Traded Concepts LLC — 0.01%
Avanza Fonder AB — 0.01%
FNY Investment Advisers LLC — 0.00%
GAMMA Investing LLC — 0.00%
Learn More about top institutional investors of Janux Therapeutics stock.
Which institutional investors are buying Janux Therapeutics stock?: In the last quarter, JANX stock was acquired by institutional investors including:
SG Americas Securities LLC
Rhumbline Advisers
FNY Investment Advisers LLC
GAMMA Investing LLC
Exchange Traded Concepts LLC
Avanza Fonder AB
Within the last year, these company insiders have bought Janux Therapeutics stock:
Ra Capital Management, LP (Director)
Ventures Xi LP Avalon (Major Shareholder)
Learn More investors buying Janux Therapeutics stock.